Elevara Medicines

To add a bio or update company history, please click update information.

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

22 Oct 2025

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.

Elevara Medicines

Life Sciences
London, United Kingdom
£50m
elevara.com
Update Information

More venture news

Big Picture Bio
18 Sept 2026
Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies
Pre-seedLife Sciences
Eterna Regeneratives
16 Sept 2026
Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair
SeedLife Sciences
Magnitude Biosciences
15 Sept 2026
Magnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms
EquityLife Sciences

Elevara Medicines

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

More venture news

Big Picture Bio raises a £1.5m pre-seed round led by Kadmos Capital and Exceptional Ventures to design cancer combination therapies

Eterna Regeneratives closes a seed round led by Hoxton Ventures and The Venture Collective to develop keratin-based enamel repair

Magnitude Biosciences raises £1.3m led by Northstar Ventures to run drug discovery screens in living nematode worms